These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31447666)

  • 1. Entanglement of CCR5 and Alzheimer's Disease.
    Li T; Zhu J
    Front Aging Neurosci; 2019; 11():209. PubMed ID: 31447666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease.
    Rosi S; Pert CB; Ruff MR; McGann-Gramling K; Wenk GL
    Neuroscience; 2005; 134(2):671-6. PubMed ID: 15979806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Peña N; Fernández-Viadero C; Berciano J
    Neurosci Lett; 2004 Aug; 366(3):312-4. PubMed ID: 15288441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease).
    Khorram Khorshid HR; Manoochehri M; Nasehi L; Ohadi M; Rahgozar M; Kamali K
    Iran J Basic Med Sci; 2012 Jul; 15(4):937-44. PubMed ID: 23493039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications.
    Si ZZ; Zou CJ; Mei X; Li XF; Luo H; Shen Y; Hu J; Li XX; Wu L; Liu Y
    Neural Regen Res; 2023 Apr; 18(4):708-715. PubMed ID: 36204826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
    Liu C; Cui G; Zhu M; Kang X; Guo H
    Int J Clin Exp Pathol; 2014; 7(12):8342-55. PubMed ID: 25674199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 receptor: biologic and genetic implications in age-related diseases.
    Balistreri CR; Caruso C; Grimaldi MP; Listì F; Vasto S; Orlando V; Campagna AM; Lio D; Candore G
    Ann N Y Acad Sci; 2007 Apr; 1100():162-72. PubMed ID: 17460174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the roles of CCR5 in learning and memory in normal and disordered states.
    Necula D; Riviere-Cazaux C; Shen Y; Zhou M
    Brain Behav Immun; 2021 Feb; 92():1-9. PubMed ID: 33276089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function.
    Hwang CJ; Park MH; Hwang JY; Kim JH; Yun NY; Oh SY; Song JK; Seo HO; Kim YB; Hwang DY; Oh KW; Han SB; Hong JT
    Oncotarget; 2016 Mar; 7(11):11984-99. PubMed ID: 26910914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
    Louboutin JP; Strayer DS
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease.
    Tamburini B; Badami GD; La Manna MP; Shekarkar Azgomi M; Caccamo N; Dieli F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the Structure and Physicochemical Properties of Potent Chemokine Receptor 5 Inhibitors for the Discovery of Novel Alzheimer's Disease Drugs.
    Mohamed Yusof NIS; Awaluddin NA; Fauzi FM
    Cent Nerv Syst Agents Med Chem; 2023; 23(2):95-108. PubMed ID: 37496242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.
    Reale M; Iarlori C; Feliciani C; Gambi D
    J Alzheimers Dis; 2008 Jun; 14(2):147-59. PubMed ID: 18560127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.
    Taylor JM; Moore Z; Minter MR; Crack PJ
    J Neural Transm (Vienna); 2018 May; 125(5):797-807. PubMed ID: 28676934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition.
    Princiotta Cariddi L; Mauri M; Cosentino M; Versino M; Marino F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease.
    Hashemiaghdam A; Mroczek M
    J Neuroimmunol; 2020 Apr; 341():577185. PubMed ID: 32045774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer's disease.
    Bajwa E; Klegeris A
    Neural Regen Res; 2022 Nov; 17(11):2342-2346. PubMed ID: 35535868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.